Category: <span>Mesothelioma News</span>

Peripheral Neuropathy Pain Reduced in Mesothelioma Patients

Avastin (bevacizumab) is a type of chemotherapy treatment that slows tumor growth by blocking the protein that is responsible for forming new blood vessels, which is what tumors need to thrive. By blocking these blood vessels, tumor growth is slowed. For those suffering from mesothelioma, hindering tumor growth can greatly improve the quality of life

more

Beagles Diagnosing Cancer ‘Could Work with Mesothelioma’

Specially trained beagles could one day detect mesothelioma by scent, according to the lead researcher of a recent study detailing the dog breed’s stunning accuracy with lung cancer. Dr. Thomas Quinn, clinical professor at the Lake Erie College of Osteopathic Medicine, believes the dogs could be equally effective with pleural mesothelioma, a rare cancer caused…

The post Beagles Diagnosing Cancer ‘Could Work with Mesothelioma’ appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

BDNF Protein Identified as a Potential Target for Mesothelioma Treatment

Mesothelioma can be difficult to diagnose and treat, with many patients not receiving a diagnosis until the later stages of the disease. Emerging research continues to explore new ways to accurately diagnose and treat the asbestos-related disease as early as possible.

Avastin Improves Quality of Life for Mesothelioma Patients

A research team from France has documented the health-related quality-of-life benefits of adding Avastin (bevacizumab) to chemotherapy for pleural mesothelioma patients, endorsing its addition to standard-of-care treatment. The recent quality-of-life analysis was a secondary endpoint of an earlier, multicenter clinical trial in France that showed an almost three-month median survival improvement when adding Avastin. The…

The post Avastin Improves Quality of Life for Mesothelioma Patients appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

States File Lawsuit Against EPA Over Asbestos Regulation

A coalition of attorneys general from 10 states and the District of Columbia has filed a federal lawsuit against the Environmental Protection Agency seeking increased scrutiny on asbestos products. The lawsuit is challenging the EPA’s reluctance to initiate tighter controls or an outright ban of asbestos within the Toxic Substances Control Act, which was revised…

The post States File Lawsuit Against EPA Over Asbestos Regulation appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Asbestos Found in Lungs of Half the Thailand Population

Almost 50% of the general population in Thailand will die with at least traces of asbestos in their lungs, based on one recent study. Asbestos fibers were discovered in the lungs of 48.5% of those who were part of a one-year, post-mortem analysis done by the Department of Pathology at Ramathibodi Hospital, Mahidol University in…

The post Asbestos Found in Lungs of Half the Thailand Population appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Less than Half of Cancer Patients Eligible for Immunotherapy Treatments

In late 2017, the FDA approved Keytruda (pembrolizumab) as an immunotherapy treatment for cancer.  It’s typically used to treat inoperable metastatic non-small cell lung cancer and melanoma but it has also been approved by the FDA to treat any unresectable or metastatic solid tumor, such as those found in mesothelioma. Immunotherapy is a type of

more

New Compound Could Make Chemotherapy More Effective

A research team from the Duke University Medical Center and the Massachusetts Institute of Technology has uncovered a new compound with potential to make chemotherapy more effective in treating various cancers. The small-molecule inhibitor drug — JH-RE-06 — showed an ability to better-sensitize tumors to Cisplatin, the popular chemotherapy drug most often used for mesothelioma…

The post New Compound Could Make Chemotherapy More Effective appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Chlor-Alkali Industry Wants Exception to Proposed US Asbestos Ban

The influential American Chemistry Council in Washington, D.C., would likely drop its opposition to an across-the-board ban on asbestos provided an exemption remains for the chlor-alkali industry. Mike Walls, ACC vice president for regulatory affairs, clarified his position last month during a congressional Environment and Climate Change subcommittee hearing to discuss the latest legislative effort…

The post Chlor-Alkali Industry Wants Exception to Proposed US Asbestos Ban appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Potential New Treatment Acts as a Sealant for Pleural Mesothelioma Tumors

Pleural mesothelioma, caused by exposure to asbestos is a rare cancer – only 3,000 cases are diagnosed in the U.S. each year – but it is highly aggressive. There is no cure for plural mesothelioma but findings published in the Journal of Thoracic and Cardiovascular Surgery reveal that a new type of combination treatment specifically

more

Colombia Ban of Asbestos Sets Example for US to Follow

Linda Reinstein was not surprised by the news last week that Colombia had joined the growing list of more than 60 countries to legislate a ban of asbestos. She saw it coming when she spoke on the topic at the University of Rosario in Bogota, Colombia, almost a year ago. She felt the intense passion…

The post Colombia Ban of Asbestos Sets Example for US to Follow appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.